News Archive | Novartis Egypt

April 2020

Media ReleaseApr 29, 2020
Novartis Egypt announces wide-ranging initiatives to respond to COVID-19 Pandemic; Supports national efforts to fight COVID-19, awareness initiatives and commits to securing its drug supply
Cairo, April 21, 2020 — As global efforts to protect and prevent against the spread of COVID-19 intensify, Novartis Egypt, including all its divisions: Pharma, Oncology, Sandoz and Technical…

October 2019

Media ReleaseOct 04, 2019
Novartis Egypt Collaborates with Ministry of Health to Promote 100 Million Seha Initiative
Cairo, 4 October 2019 – Novartis Pharma S.A.E (Novartis Egypt) organized an educational forum for healthcare practitioners as part of its efforts to support the Egyptian Ministry of Health (MoH)’s…
Media ReleaseOct 04, 2019
نوفارتس مصر تتعاون مع وزارة الصحة من اجل دعم مبادرة ١٠٠ مليون صحة
القاهرة، ٤ أكتوبر ٢٠١٩ - في إطار تعاونها الوثيق مع وزارة الصحة المصرية، نظمت شركة نوفارتس فارما ش.م.م. (نوفارتس مصر) ندوة تثقيفية لمقدمي خدمات الرعاية الصحية وذلك في سياق دعم مبادرة الرعاية الصحية…

October 2018

July 2018

Media ReleaseJul 31, 2018
Novartis Pharma S.A.E confirms all company products in Egypt unaffected by valsartan recall
Cairo, July 31, 2018 – Novartis Pharma S.A.E (Novartis Pharma) confirms that none of its products in Egypt are affected by the decision to recall certain products containing valsartan All Novartis…

May 2018

Media ReleaseMay 06, 2018
Novartis Egypt celebrates its 22nd annual community partnership day alongside more than 23,000 associates worldwide with a massive blood donation campaign
In Egypt, associates from Novartis Egypt (Novartis Pharma S.A.E and its divisions: Oncology, Sandoz Egypt and Alcon) are giving back to their communities through a widespread Social Responsibility…

March 2018

Media ReleaseMar 01, 2018
“I Love Life” Showcased During CardioEgypt 2018’s Proceedings
1 in 5 people over the age of 40 will develop Heart Failure in their lifetime1 Sacubitril/valsartan Shows 20% Reduction in Risk of Cardiovascular Death Giving New Hope to Those Living with Heart…

November 2017

Media ReleaseNov 24, 2017
New Hope for Organ Transplant Patients in Egypt
Novartis TRANSFORM confirms strong efficacy of EVEROLIMUS-based regimen with lower exposure to nephrotoxic calcineurin inhibitor (CNI)1 The Novartis study is the largest de novo interventional study…

October 2017

Media ReleaseOct 13, 2017
"LOVE LIVE" - Healthcare organizations mark the launch of nationwide heart failure awareness campaign
Study reveals Egyptian heart failure patients affected by the disease at an average age of 57, nearly 10-13 years younger than their European counterparts1 Cairo, 13 October, 2017 - The Magdi Yacoub…